Study guide

9.1 Coagulopathies & Transfusion Therapy

AACN CCRN Adult

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Strategy

1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy

2 Cardiovascular I — Hemodynamics & Shock

2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology

3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias

3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS

4 Respiratory I -- Failure, ABGs & Acute Conditions

4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma

5 Respiratory II — Mechanical Ventilation

5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications

6 Endocrine Emergencies

6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises

7 Renal & Genitourinary

7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy

8 Gastrointestinal

8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition

9 Hematology, Immunology & Integumentary

9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries

10 Neurological I — Stroke, TBI & ICP

10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring

11 Neurological II & Musculoskeletal

11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal

12 Behavioral & Psychosocial

12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

13 Multisystem I — Sepsis & MODS

13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response

14 Multisystem II — Trauma, Burns & Toxicology

14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies

15 Synergy Model, Advocacy & Caring

15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices

16 Collaboration, Systems Thinking & Diversity

16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning

17 Clinical Inquiry, Ethics & End-of-Life

17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care

9.1 Coagulopathies & Transfusion Therapy

Key Takeaways Explain This Topic AI

DIC is consumptive: low platelets, low fibrinogen, prolonged PT/aPTT, and a high D-dimer; treat the underlying cause plus targeted blood products.

HIT causes a >50% platelet drop on day 5-10 with thrombosis; stop ALL heparin and start a direct thrombin inhibitor such as argatroban.

Massive transfusion uses a balanced 1:1:1 ratio of PRBCs:FFP:platelets; watch the lethal triad of hypothermia, acidosis, and coagulopathy.

Acute hemolytic (ABO) reactions cause fever, flank pain, and red urine within minutes - stop the transfusion immediately.

Rapid or massive transfusion causes citrate-induced hypocalcemia (perioral tingling, prolonged QT) treated with IV calcium.

Last updated: July 2026

Disseminated Intravascular Coagulation (DIC)

Disseminated intravascular coagulation (DIC) is a consumptive coagulopathy : an underlying insult triggers uncontrolled, systemic activation of the clotting cascade. Circulating tissue factor and inflammatory cytokines drive fibrin generation throughout the microvasculature, so the patient forms microthrombi (causing ischemic organ injury) while simultaneously consuming platelets and clotting factors faster than the marrow and liver can replace them . The paradox the CCRN loves to test is that the patient clots and bleeds at the same time. Common triggers are sepsis (the most frequent ICU cause), major trauma, burns, obstetric catastrophes (abruption, amniotic fluid embolism), acute promyelocytic leukemia, and severe hemolytic transfusion reactions.

Recognition and laboratory pattern

Clinically you see diffuse oozing from IV sites, incisions, gums, and suction catheters together with petechiae, purpura, and evidence of end-organ hypoperfusion (oliguria, delirium, acral cyanosis). Memorize the lab signature as a set:

  • Parameter DIC finding Why
  • Platelets Low / falling Consumed in microthrombi
  • Fibrinogen Low (<100-150 mg/dL) Consumed forming fibrin
  • PT / aPTT Prolonged Clotting factors depleted
  • D-dimer / FDPs Markedly elevated Fibrinolysis of formed clots
  • Peripheral smear Schistocytes RBCs sheared by fibrin strands

A rising D-dimer with a falling fibrinogen and platelet count in a septic or post-trauma patient is DIC until proven otherwise.

Management

The single most important intervention is to treat the precipitating cause - antibiotics and source control for sepsis, delivery for obstetric DIC, ATRA for acute promyelocytic leukemia. DIC never resolves while the trigger burns. Blood-product support is guided by active bleeding plus labs, not numbers in isolation : give fresh frozen plasma (FFP) to replace consumed factors when PT/aPTT are prolonged, cryoprecipitate when fibrinogen falls below roughly 100-150 mg/dL, and platelets for counts under 20,000-50,000/uL when the patient is bleeding or facing a procedure. Heparin has a narrow role limited to thrombosis-predominant DIC (for example purpura fulminans) and is generally avoided when bleeding dominates.

Heparin-Induced Thrombocytopenia (HIT)

Heparin-induced thrombocytopenia (HIT) is an immune, prothrombotic drug reaction: IgG antibodies form against the heparin-platelet factor 4 (PF4) complex , activating platelets and coagulation. Despite the falling platelet count, the danger is thrombosis, not bleeding - venous and arterial clots, limb ischemia, and pulmonary embolism.

Use the 4Ts to gauge probability: T hrombocytopenia (typically a >50% drop), T iming ( day 5-10 of exposure, or faster with prior heparin), T hrombosis (new clot), and a T ternate cause absent. A platelet drop from 250,000 to 80,000/uL on day 6 of a heparin infusion with a new arterial thrombus is a textbook picture.

The two non-negotiable steps

Stop ALL heparin immediately - infusions, subcutaneous prophylaxis, low-molecular-weight heparin, and even heparin-coated catheter flushes.

Start a non-heparin anticoagulant - a direct thrombin inhibitor such as argatroban (hepatically cleared, useful in renal disease) or bivalirudin.

Do not transfuse platelets prophylactically (adds fuel to thrombosis) and do not start warfarin until the platelet count recovers above roughly 150,000/uL, because early warfarin can precipitate venous limb gangrene . Send a HIT antibody/serotonin-release assay, but treat empirically when clinical probability is high.

Thrombocytopenia in the ICU

Beyond HIT and DIC, ICU thrombocytopenia stems from dilution (massive transfusion), sepsis, TTP/HUS, drugs, and devices (IABP, ECMO, CRRT). The spontaneous bleeding risk rises steeply below 10,000-20,000/uL ; most procedures need >50,000, and neuraxial or neurosurgical procedures need about 100,000. Avoid IM injections, apply pressure at puncture sites, and hold offending drugs.

Transfusion Therapy

Each product corrects a specific deficit:

  • Product Contents Main indication Typical effect
  • PRBCs Red cells Symptomatic anemia; restrictive Hgb <7 (<8 cardiac) +1 g/dL Hgb per unit
  • FFP All clotting factors Prolonged PT/PTT with bleeding; warfarin reversal Replaces factors
  • Platelets Platelets <10k prophylaxis; <50k bleeding/procedure +30-50k per pool
  • Cryoprecipitate Fibrinogen, VIII, XIII, vWF Fibrinogen <100-150 mg/dL Raises fibrinogen
  • Massive transfusion protocol (MTP)

For life-threatening hemorrhage, resuscitate with a balanced 1:1:1 ratio of PRBCs:FFP:platelets that approximates whole blood, limit crystalloid, and give tranexamic acid early in trauma. Watch the lethal triad - hypothermia, acidosis, and coagulopathy - which worsens bleeding; warm all products and the patient.

Transfusion reactions

Reaction Timing / clue Action

Acute hemolytic (ABO) Minutes; fever, flank pain, hypotension, red urine Stop, saline, protect kidneys ; clerical check

  • TRALI <6 h; hypoxemia, bilateral infiltrates, normal filling Stop, respiratory support; NOT diuresis
  • TACO Volume overload, hypertension, JVD Stop, diurese , slow rate
  • Febrile non-hemolytic Fever/chills, no hemolysis Stop, antipyretic; leukoreduce
  • Allergic/anaphylaxis Urticaria to shock Antihistamine; epinephrine if severe
  • Citrate toxicity Rapid/massive PRBC; perioral tingling, prolonged QT IV calcium

For any acute reaction the first action is stop the transfusion and maintain the line with normal saline . Citrate/hypocalcemia is a tested favorite: stored blood is anticoagulated with citrate, which chelates calcium during rapid transfusion, producing perioral tingling, a prolonged QT interval, and a low ionized calcium - treated with IV calcium (chloride or gluconate).

TRALI versus TACO

These two are the highest-yield discriminators on the exam because both cause dyspnea and hypoxemia soon after transfusion but demand opposite treatment. Transfusion-related acute lung injury (TRALI) is an immune, non-cardiogenic injury: within 6 hours the patient develops bilateral pulmonary infiltrates and hypoxemia with normal filling pressures and a normal or low CVP - fluid overload is absent, so diuretics do NOT help and management is supportive respiratory care and often intubation. Transfusion-associated circulatory overload (TACO) is volume overload: hypertension, jugular venous distention, an S3, and a rising CVP - the correct response is to slow or stop the transfusion and diurese . When in doubt, the blood pressure and filling pressures separate them: high with TACO, normal or low with TRALI.

Reversal beyond FFP

For urgent reversal of warfarin with life-threatening bleeding, four-factor prothrombin complex concentrate (PCC) plus IV vitamin K is faster and lower-volume than FFP and is preferred when available. Recognizing that DIC, dilution, and vitamin-K deficiency each demand a different product is exactly the reasoning the CCRN tests: match the deficit to the correct component rather than transfusing reflexively.